Browse Stanford University | Stanford Profiles

BioDr. Regmi earned her PhD in Pharmacy from Yeungnam University, South Korea. Before joining us, she was a postdoctoral fellow in the Department of Radiology under the mentorship of Dr. Avnesh S. Thakor. With over a decade of experience researching novel therapies for inflammatory diseases and expertise in cell therapy, Dr. Regmi brings valuable skills in in vivo and in vitro experimental biology, immunology, complex multicolor flow cytometry, and scientific writing. Her expertise will be instrumental in advancing the Rosen Lab’s research on the molecular mechanisms underlying pediatric IBD and treatment response.
Dr. Regmi’s work will focus on investigating the role of stromal-immune crosstalk that drives ulcerative colitis.

Donald Regula, MD

Professor (Teaching) of Pathology, Emeritus

BioDr. Regula was the course director for the required medical student course, Science of Medicine, and previously the course director of the required pathology course (1993-2020)
He was the Director of the Stanford Autopsy Service (1995-2021)
He is the faculty co-lead for the EPIC Beaker-AP implementation project.

David Rehkopf

Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy

BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.

I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.

My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.

Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.

Contact Info

Web page:

http://web.stanford.edu/people/drehkopf

Rida Rehman

Postdoctoral Scholar, Pathology

Contact Info
ridareh@stanford.edu

James H Reich

Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)

BioI attended U.C. Berkeley for my B.S. degree, the University of Colorado for my MD and U.C. Davis for my psychiatric residency and did a fellowship in Psychiatric Epidemiology at Yale. I have been faculty at the University of Iowa, Harvard and Brown. I have published over a hundred papers in peer reviewed journals, mostly in the areas of anxiety and personality. I also founded a medical society, the Association for Research in Personality Disorders (ARPD).

Currently I am in private practice in San Francisco and teach at Stanford and UCSF. My treatment approaches for psychotherapy include CBT and mindfulness. I also do psychopharmacology which I have taught UCSF for many years.

I am also a board certified forensic psychiatrist in private practice focusing largely on civil cases.